Clostridium difficile Colitis: A Review

References

• . Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med. 1978;298(10):531–534
   PubMed Web of Science ®Google Scholar
• . Cohen SH, Gerding DN, Johnson S, ; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–455
   PubMed Web of Science ®Google Scholar
• . McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis. 2006;12(3):409–415
   PubMed Web of Science ®Google Scholar
• . Fawley WN, Wilcox MH. Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect. 2001;126(3):343–350
   PubMed Web of Science ®Google Scholar
• . O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28(11):1219–1227
   PubMedGoogle Scholar
• . Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981;81(1):5–9
   PubMed Web of Science ®Google Scholar
• . Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerg Infect Dis. 2010;16(4):604–609
   PubMed Web of Science ®Google Scholar
• . Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169(1):127–133
   PubMedGoogle Scholar
• . McFarland LV, Mulligan ME, Kowk RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204–210
   PubMed Web of Science ®Google Scholar
• . Kim KH, Fekety R, Batts DH, . Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50
   PubMed Web of Science ®Google Scholar
• . Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109–114
   PubMed Web of Science ®Google Scholar
• . Toshniwal R, Silva J Jr, Fekety R, Kim KH. Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. J Infect Dis. 1981;143(1):51–54
   PubMedGoogle Scholar
• . Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis. 2004;38(5):646–648
   PubMed Web of Science ®Google Scholar
• . Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989–2995
   PubMed Web of Science ®Google Scholar
• . Shah S, Lewis A, Leopold D, Dunstan F, Woodhouse K. Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM. 2000;93(3):175–181
   PubMedGoogle Scholar
• . Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243–245
   PubMed Web of Science ®Google Scholar
• . Khanna S, Pardi DS, Aronson SL, . The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89–95
   PubMed Web of Science ®Google Scholar
• . Loo VG, Poirier L, Miller MA, . A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–2249
   PubMed Web of Science ®Google Scholar
• . McDonald LC, Killgore GE, Thompson A, . An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433–2441
   PubMed Web of Science ®Google Scholar
• . O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136(6):1913–1924
   PubMedGoogle Scholar
• . Wanahita A, Goldsmith EA, Marino BJ, Musher DM. Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med. 2003;115(7):543–546
   PubMedGoogle Scholar
• . Wolf LE, Gorbach SL, Granowitz EV. Extraintestinal Clostridium difficile: 10 years' experience at a tertiary-care hospital. Mayo Clin Proc. 1998;73(10):943–947
   PubMedGoogle Scholar
• . Freiler JF, Durning SJ, Ender PT. Clostridium difficile small bowel enteritis occurring after total colectomy. Clin Infect Dis. 2001;33(8):1429–1431; discussion 1432
   PubMed Web of Science ®Google Scholar
• . Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis. 1992;15(4):573–581
   PubMed Web of Science ®Google Scholar
• . Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am. 2010;94(1):135–153
   PubMedGoogle Scholar
• . Kariv R, Naveneethan U, Venkatesh PG, Lopez R. Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5(1):34–40
   PubMed Web of Science ®Google Scholar
• . Schaier M, Wendt C, Zeier M, Ritz E. Clostridium difficile diarrhoea in the immunosuppressed patient—update on prevention and management. Nephrol Dial Transplant. 2004;19(10):2432–2436
   PubMed Web of Science ®Google Scholar
• . Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis. 1993;16( suppl 4):S439–S442
   PubMedGoogle Scholar
• . Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med. 1995;123(11):835–840
   PubMedGoogle Scholar
• . Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol. 2011;64(1):1–5
   PubMed Web of Science ®Google Scholar
• . Barbut F, Lalande V, Daprey G, . Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases. Eur J Clin Microbiol Infect Dis. 2000;19(6):481–484
   PubMedGoogle Scholar
• . Kufelnicka AM, Kirn TJ. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis. 2011;52(12):1451–1457
   PubMedGoogle Scholar
• . Swindells J, Brenwald N, Reading N, Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol. 2010;48(2):606–608
   PubMed Web of Science ®Google Scholar
• . Aichinger E, Schleck CD, Harmsen WA, Nyre LM, Patel R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):3795–3797
   PubMed Web of Science ®Google Scholar
• . Mohan SS, McDermott BP, Parchuri S, Cunha BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med. 2006;119(4):356.e7–e8
   Google Scholar
• . Luo RF, Banaei N. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol. 2010;48(10):3738–3741
   PubMed Web of Science ®Google Scholar
• . Gerding DN, Olson MM, Peterson LR, . Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med. 1986;146(1):95–100
   PubMedGoogle Scholar
• . Wullt M, Odenholt I, Walder M. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol. 2003;24(10):765–768
   PubMed Web of Science ®Google Scholar
• . Gordin FM, Schultz ME, Huber RA, Gill JA. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26(7):650–653
   PubMed Web of Science ®Google Scholar
• . Johnson S, Gerding DN, Olson MM. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med. 1990;88(2):137–140
   PubMed Web of Science ®Google Scholar
• . Berild D, Smaabrekke L, Halvorsen DS, Lelek M, Stahlsberg EM, Ringertz SH. Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals. J Hosp Infect. 2003;54(3):202–206
   PubMedGoogle Scholar
• . Boyce JM, Havill NL, Otter JA, . Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723–729
   PubMed Web of Science ®Google Scholar
• . Teasley DG, Gerding DN, Olson MM, . Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983;2(8358):1043–1046
   PubMed Web of Science ®Google Scholar
• . Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22(5):813–818
   PubMed Web of Science ®Google Scholar
• . Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1995;44(RR-12):1–13
   Google Scholar
• . Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986;27(10):1169–1172
   PubMed Web of Science ®Google Scholar
• . Ings RM, McFadzean JA, Ormerod WE. The fate of metronidazole and its implications in chemotherapy. Xenobiotica. 1975;5(4):223–235
   PubMed Web of Science ®Google Scholar
• . Johnson S, Homann SR, Bettin KM. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med. 1992;117(4):297–302
   PubMed Web of Science ®Google Scholar
• . Peláez T, Alcalá L, Alonso R, Rodríquez-Créixems M, García-Lechuz JM, Bouza E. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother. 2002;46(6):1647–1650
   PubMedGoogle Scholar
• . Baines SD, O'Connor R, Freeman J, . Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother. 2008;62(5):1046–1052
   PubMed Web of Science ®Google Scholar
• . Musher DM, Aslam S, Logan N, . Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005;40(11):1586–1590
   PubMed Web of Science ®Google Scholar
• . Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45(3):302–307
   PubMed Web of Science ®Google Scholar
• . Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis. 2002;35(6):690–696
   PubMed Web of Science ®Google Scholar
• . Lamontagne F, Labbé AC, Haeck O, . Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267–272
   PubMed Web of Science ®Google Scholar
• . Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis. 2007;44(6):846–848
   PubMed Web of Science ®Google Scholar
• . Curry SR, Marsh JW, Shutt KA, . High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis. 2009;48(4):425–429
   PubMed Web of Science ®Google Scholar
• . Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36(5):580–585
   PubMed Web of Science ®Google Scholar
• . Gough E, Shaikh, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994–1002
   PubMed Web of Science ®Google Scholar
• . Louie TJ, Miller MA, Mullane KM, ; OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–431
   PubMed Web of Science ®Google Scholar
• . Mullane KM, Miller MA, Weiss K, . Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53(5):440–447
   PubMed Web of Science ®Google Scholar
• . Musher DM, Logan N, Hamill RJ, . Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006;43(4):421–427
   PubMed Web of Science ®Google Scholar
• . Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009;48(4):e41–e46
   PubMed Web of Science ®Google Scholar
• . Louie TJ, Peppe J, Watt CK, ; Tolevamer Study Investigator Group. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis. 2006;43(4):411–420
   PubMed Web of Science ®Google Scholar
• . Louie T, Gerson M, Grimard D, . Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in Clostridium difficile-associated diarrhea (CDAD). Presented at: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting of the American Society for Microbiology; September 7–20, 2007; Washington, DC. Abstract K-425A
   Google Scholar
• . Herpers BL, Vlaminckx B, Burkhardt O, . Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection. Clin Infect Dis. 2009;48(12):1732–1735
   PubMed Web of Science ®Google Scholar
• . McFarland LV, Surawicz CM, Greenberg RN, . A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271(24):1913–1918
   PubMed Web of Science ®Google Scholar
• . McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101(4):812–822
   PubMed Web of Science ®Google Scholar
• . Muñoz P, Bouza E, Cuenca-Estrella M, . Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625–1634
   PubMedGoogle Scholar
• . Hickson M, D'Souza AL, Muthu N, . Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335(7610):80
   PubMed Web of Science ®Google Scholar
• . Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet. 2001;357(9251):189–193
   PubMed Web of Science ®Google Scholar
• . Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;53(5):882–884
   PubMed Web of Science ®Google Scholar
• . McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum. 2006;49(5):640–645
   PubMed Web of Science ®Google Scholar
• . Lowy I, Molrine DC, Leav BA, . Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362(3):197–205
   PubMed Web of Science ®Google Scholar
• . Gerding DN, Johnson S. Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis. 2010;51(11):1306–1313
   PubMed Web of Science ®Google Scholar
• . Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004;47(10):1620–1626
   PubMed Web of Science ®Google Scholar